top of page
  • White Facebook Icon
  • White Twitter Icon

Tech Transfer, Process Characterization, Process Validations, CPV and APQR Expertise for BioPharma 

Bench-2-Batch-2 Batch

End-to-end Phase appropriate CMC support

ChatGPT Image Oct 31, 2025, 06_47_58 PM_
ChatGPT Image Oct 31, 2025, 06_47_58 PM_
ChatGPT Image Oct 31, 2025, 10_22_44 PM_
Streamline Chemistry, Manufacturing, and Controls (CMC)

Biopharma startups and established companies face the same challenge: scientific innovation alone
doesn’t secure approval

It takes disciplined execution in validation, documentation, and regulatory compliance

Bench2Batch bridges this gap,
providing the expertise and
structure you need to move
fast while staying compliant

Naveenganesh (Naveen)
Muralidharan

Founder & Principal Consultant

Visionary biopharmaceutical leader with 20 years of global expertise in GMP manufacturing, tech transfer, and end-to-end process validation. Proven track record advancing biologics and gene therapy from development to launch. Known for leading high-performing teams, ensuring FDA/EMA compliance, and driving first-time-right execution across MSAT, PD, and manufacturing.

  • LinkedIn

On-line Bioreactor Scale Up & Scale Down Calculators

These online bioreactor calculators simplify the process of scaling up or down between bench and production scale. They offer tools to predict pCO2, assess shear from impellers and sparging, and

calculate OTR and KLa. This helps users optimize process conditions and improve scalability

across different reactor sizes.

Technical Insights

TESTIMONIALS

Mark Davis, Director MSAT @ AGC Biologics, CO USA

“Naveen is one of the most capable engineers I have worked with. His ability to understand complex scientific and statistical ideas stands above most bioprocess professionals. He understands upstream, harvest, and CIP/SIP operations at practical and theoretical levels. On top of that, he understands regulatory needs for commercialization of bioprocess products. A fantastic asset for a large or small company with commercial aspirations.”
bottom of page